share_log

Processa Pharma Q3 2024 GAAP EPS $(1.03) Misses $(1.00) Estimate

Benzinga ·  Oct 31, 2024 05:00

Processa Pharma (NASDAQ:PCSA) reported quarterly losses of $(1.03) per share which missed the analyst consensus estimate of $(1.00) by 3 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment